Skip to main content

Mycosis Fungoides clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for
  • A Study of Skin Diseases Brought About by Irregular Immune System Response

    “Help researchers learn more about immune cells that contribute to skin disease”

    open to eligible people ages 18-55

    This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our knowledge about immune mediated skin disease.

    Sacramento, California

  • Study of Experimental medicine, Anti-ICOS Monoclonal Antibody MEDI-570, in the treatment of Non-Hodgkin's Lymphoma

    “Immunotherapy (Anti-ICOS Monoclonal Antibody MEDI-570) study of side effects, best dose, and helpfulness in treatment of Lymphoma”

    open to eligible people ages 18 years and up

    This phase I trial studies the side effects and best dose of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 in treating patients with peripheral T-cell lymphoma follicular variant or angioimmunoblastic T-cell lymphoma that has returned after a period of improvement (relapsed) or has not responded to previous treatment (refractory). Immunotherapy with monoclonal antibodies, such as anti-ICOS monoclonal antibody MEDI-570, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread.

    Sacramento, California and other locations